| Product NDC: | 10019-644 | 
| Proprietary Name: | Suprane | 
| Non Proprietary Name: | DESFLURANE | 
| Active Ingredient(s): | 240 mL/240mL & nbsp; DESFLURANE | 
| Administration Route(s): | RESPIRATORY (INHALATION) | 
| Dosage Form(s): | LIQUID | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 10019-644 | 
| Labeler Name: | Baxter Healthcare Corporation | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA020118 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 19920918 | 
| Package NDC: | 10019-644-34 | 
| Package Description: | 6 BOTTLE, GLASS in 1 CARTON (10019-644-34) > 240 mL in 1 BOTTLE, GLASS (10019-644-64) | 
| NDC Code | 10019-644-34 | 
| Proprietary Name | Suprane | 
| Package Description | 6 BOTTLE, GLASS in 1 CARTON (10019-644-34) > 240 mL in 1 BOTTLE, GLASS (10019-644-64) | 
| Product NDC | 10019-644 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | DESFLURANE | 
| Dosage Form Name | LIQUID | 
| Route Name | RESPIRATORY (INHALATION) | 
| Start Marketing Date | 19920918 | 
| Marketing Category Name | NDA | 
| Labeler Name | Baxter Healthcare Corporation | 
| Substance Name | DESFLURANE | 
| Strength Number | 240 | 
| Strength Unit | mL/240mL | 
| Pharmaceutical Classes | General Anesthesia [PE],General Anesthetic [EPC] |